Your browser doesn't support javascript.
loading
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.
Moritz, Amy E; Free, R Benjamin; Weiner, Warren S; Akano, Emmanuel O; Gandhi, Disha; Abramyan, Ara; Keck, Thomas M; Ferrer, Marc; Hu, Xin; Southall, Noel; Steiner, Joseph; Aubé, Jeffrey; Shi, Lei; Frankowski, Kevin J; Sibley, David R.
Afiliação
  • Moritz AE; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, Intramural Research Program, National Institutes of Health, 35 Convent Drive, MSC-3723, Bethesda, Maryland 20892-3723, United States.
  • Free RB; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, Intramural Research Program, National Institutes of Health, 35 Convent Drive, MSC-3723, Bethesda, Maryland 20892-3723, United States.
  • Weiner WS; University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, Kansas 66047, United States.
  • Akano EO; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, Intramural Research Program, National Institutes of Health, 35 Convent Drive, MSC-3723, Bethesda, Maryland 20892-3723, United States.
  • Gandhi D; Center for Integrative Chemical Biology and Drug Discovery, UNC Eshelman School of Pharmacy, 125 Mason Farm Road, Chapel Hill, North Carolina 27599, United States.
  • Abramyan A; Computational Chemistry and Molecular Biophysics Unit, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, Maryland, 333 Cassell Drive, Baltimore, Maryland 21224, United States.
  • Keck TM; Department of Chemistry & Biochemistry, Department of Molecular & Cellular Biosciences, College of Science and Mathematics, Rowan University, 201 Mullica Hill Road, Glassboro, New Jersey 08028, United States.
  • Ferrer M; NIH Chemical Genomics Center, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States.
  • Hu X; NIH Chemical Genomics Center, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States.
  • Southall N; NIH Chemical Genomics Center, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States.
  • Steiner J; NeuroTherapeutics Development Unit, National Institute for Neurological Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda, Maryland 20892, United States.
  • Aubé J; University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, Kansas 66047, United States.
  • Shi L; Center for Integrative Chemical Biology and Drug Discovery, UNC Eshelman School of Pharmacy, 125 Mason Farm Road, Chapel Hill, North Carolina 27599, United States.
  • Frankowski KJ; Computational Chemistry and Molecular Biophysics Unit, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, Maryland, 333 Cassell Drive, Baltimore, Maryland 21224, United States.
  • Sibley DR; University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, Kansas 66047, United States.
J Med Chem ; 63(10): 5526-5567, 2020 05 28.
Article em En | MEDLINE | ID: mdl-32342685

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Agonistas de Dopamina / Receptores de Dopamina D3 / Descoberta de Drogas Limite: Animals / Humans / Male Idioma: En Revista: J Med Chem Assunto da revista: QUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Agonistas de Dopamina / Receptores de Dopamina D3 / Descoberta de Drogas Limite: Animals / Humans / Male Idioma: En Revista: J Med Chem Assunto da revista: QUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos